Salveen Richter
Stock Analyst at Goldman Sachs
(4.57)
# 993
Out of 5,090 analysts
563
Total ratings
49.1%
Success rate
11%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Reiterated: Buy | $550 → $320 | $165.00 | +93.94% | 23 | Oct 30, 2026 | |
| AMRX Amneal Pharmaceuticals | Reiterated: Buy | $24 | $21.51 | +11.58% | 1 | Oct 29, 2026 | |
| GILD Gilead Sciences | Reiterated: Hold | $142 → $155 | $170.68 | -9.19% | 18 | Oct 29, 2026 | |
| AMGN Amgen | Reiterated: Buy | $450 → $481 | $466.01 | +3.22% | 24 | Oct 25, 2026 | |
| MRNA Moderna | Reiterated: Hold | $137 | $221.72 | -38.21% | 50 | Oct 25, 2026 | |
| SMMT Summit Therapeutics | Reiterated: Buy | $41 → $43 | $16.03 | +168.25% | 8 | Oct 25, 2026 | |
| VRTX Vertex Pharmaceuticals | Reiterated: Buy | $653 → $654 | $558.88 | +17.02% | 31 | Oct 25, 2026 | |
| RAPP Rapport Therapeutics | Reiterated: Buy | $62 → $68 | $25.05 | +171.46% | 6 | Oct 21, 2026 | |
| TLV: TEVA Teva Pharmaceutical Industries Limited | Reiterated: Buy | ILA 15,545 | ILA 12,800 | +21.45% | 1 | Oct 12, 2026 | |
| VTRS Viatris | Reiterated: Hold | $20 | $19.04 | +5.07% | 4 | Oct 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $972 | $927.89 | +4.75% | 26 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $46 → $31 | $24.83 | +24.85% | 24 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $56 | $43.52 | +28.68% | 20 | Sep 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $21.51 | +123.15% | 2 | Sep 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $28 → $19 | $16.10 | +18.01% | 15 | Sep 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $73 | $13.95 | +423.30% | 1 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $69 → $70 | $58.51 | +19.64% | 18 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $4.13 | +214.77% | 7 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $48 → $55 | $51.42 | +6.96% | 17 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 | $4.05 | +72.84% | 2 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $9 | $12.47 | -27.83% | 18 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $67 → $80 | $44.25 | +80.79% | 7 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $110 → $118 | $120.39 | -1.99% | 27 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32 | $30.55 | +4.75% | 17 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $11.90 | +177.31% | 13 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $31 | $18.35 | +68.94% | 12 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $250 | $253.62 | -1.43% | 31 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 | $22.94 | +78.73% | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $18.21 | +92.20% | 3 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $26 | $14.46 | +79.81% | 2 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 → $17 | $18.62 | -8.70% | 23 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 | $18.19 | n/a | 6 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $15 → $17 | $20.59 | n/a | 11 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 | $10.82 | n/a | 1 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 → $40 | $18.94 | n/a | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.01 | n/a | 9 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $39 | $2.44 | n/a | 1 | Apr 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 → $30 | $13.65 | n/a | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $48 → $5 | $26.64 | n/a | 8 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $74.95 | n/a | 1 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $62.48 | n/a | 1 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53 | $67.18 | n/a | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $7 | $2.67 | n/a | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $31 | $1.18 | n/a | 10 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $225 | $249.61 | n/a | 2 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $22 | $4.72 | n/a | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $30 → $7 | $11.04 | n/a | 2 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 → $1 | $7.06 | n/a | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $9 | $4.03 | n/a | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $34 → $6 | $2.57 | n/a | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $28 → $30 | $3.45 | n/a | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $126 → $131 | $430.36 | n/a | 7 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $11 | $1.08 | n/a | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 | $3.58 | n/a | 1 | Oct 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $45 → $47 | $59.90 | n/a | 2 | May 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $4 → $2 | $6.20 | n/a | 3 | Nov 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $44 → $76 | $598.72 | n/a | 3 | Oct 29, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $18 → $2 | $1.92 | n/a | 2 | Oct 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $0.0001 | n/a | 1 | Dec 2, 2011 |
Alnylam Pharmaceuticals
Oct 30, 2026
Reiterated: Buy
Price Target: $550 → $320
Current: $165.00
Upside: +93.94%
Amneal Pharmaceuticals
Oct 29, 2026
Reiterated: Buy
Price Target: $24
Current: $21.51
Upside: +11.58%
Gilead Sciences
Oct 29, 2026
Reiterated: Hold
Price Target: $142 → $155
Current: $170.68
Upside: -9.19%
Amgen
Oct 25, 2026
Reiterated: Buy
Price Target: $450 → $481
Current: $466.01
Upside: +3.22%
Moderna
Oct 25, 2026
Reiterated: Hold
Price Target: $137
Current: $221.72
Upside: -38.21%
Summit Therapeutics
Oct 25, 2026
Reiterated: Buy
Price Target: $41 → $43
Current: $16.03
Upside: +168.25%
Vertex Pharmaceuticals
Oct 25, 2026
Reiterated: Buy
Price Target: $653 → $654
Current: $558.88
Upside: +17.02%
Rapport Therapeutics
Oct 21, 2026
Reiterated: Buy
Price Target: $62 → $68
Current: $25.05
Upside: +171.46%
Teva Pharmaceutical Industries Limited
Oct 12, 2026
Reiterated: Buy
Price Target: ILA 15,545
Current: ILA 12,800
Upside: +21.45%
Viatris
Oct 8, 2026
Reiterated: Hold
Price Target: $20
Current: $19.04
Upside: +5.07%
Oct 1, 2026
Reiterated: Buy
Price Target: $972
Current: $927.89
Upside: +4.75%
Sep 30, 2026
Rated: Hold
Price Target: $46 → $31
Current: $24.83
Upside: +24.85%
Sep 14, 2026
Reiterated: Hold
Price Target: $56
Current: $43.52
Upside: +28.68%
Sep 8, 2026
Reiterated: Buy
Price Target: $48
Current: $21.51
Upside: +123.15%
Sep 4, 2026
Reiterated: Hold
Price Target: $28 → $19
Current: $16.10
Upside: +18.01%
Sep 1, 2026
Reiterated: Buy
Price Target: $73
Current: $13.95
Upside: +423.30%
Aug 31, 2026
Reiterated: Hold
Price Target: $69 → $70
Current: $58.51
Upside: +19.64%
Aug 11, 2026
Reiterated: Buy
Price Target: $13
Current: $4.13
Upside: +214.77%
Aug 10, 2026
Rated: Hold
Price Target: $48 → $55
Current: $51.42
Upside: +6.96%
Aug 6, 2026
Reiterated: Hold
Price Target: $7
Current: $4.05
Upside: +72.84%
Aug 6, 2026
Reiterated: Sell
Price Target: $9
Current: $12.47
Upside: -27.83%
Aug 5, 2026
Rated: Buy
Price Target: $67 → $80
Current: $44.25
Upside: +80.79%
Jul 29, 2026
Reiterated: Hold
Price Target: $110 → $118
Current: $120.39
Upside: -1.99%
Jul 21, 2026
Reiterated: Hold
Price Target: $32
Current: $30.55
Upside: +4.75%
Jul 20, 2026
Reiterated: Buy
Price Target: $33
Current: $11.90
Upside: +177.31%
Jul 20, 2026
Reiterated: Buy
Price Target: $22 → $31
Current: $18.35
Upside: +68.94%
Jul 13, 2026
Reiterated: Buy
Price Target: $250
Current: $253.62
Upside: -1.43%
Jun 1, 2026
Reiterated: Buy
Price Target: $41
Current: $22.94
Upside: +78.73%
May 13, 2026
Reiterated: Buy
Price Target: $35
Current: $18.21
Upside: +92.20%
Apr 9, 2026
Reiterated: Buy
Price Target: $14 → $26
Current: $14.46
Upside: +79.81%
Feb 25, 2026
Reiterated: Hold
Price Target: $19 → $17
Current: $18.62
Upside: -8.70%
Oct 30, 2025
Reiterated: Hold
Price Target: $16
Current: $18.19
Upside: n/a
Aug 7, 2025
Reiterated: Sell
Price Target: $15 → $17
Current: $20.59
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $19
Current: $10.82
Upside: n/a
Jan 28, 2025
Reiterated: Buy
Price Target: $46 → $40
Current: $18.94
Upside: n/a
Dec 19, 2024
Rated: Hold
Price Target: n/a
Current: $8.01
Upside: n/a
Apr 2, 2024
Initiated Coverage: Hold
Price Target: $39
Current: $2.44
Upside: n/a
Mar 5, 2024
Reiterated: Buy
Price Target: $37 → $30
Current: $13.65
Upside: n/a
Feb 16, 2024
Reiterated: Hold
Price Target: $48 → $5
Current: $26.64
Upside: n/a
Jan 8, 2024
Reiterated: Buy
Price Target: n/a
Current: $74.95
Upside: n/a
Jan 5, 2024
Reiterated: Buy
Price Target: n/a
Current: $62.48
Upside: n/a
Jul 31, 2023
Reiterated: Buy
Price Target: $53
Current: $67.18
Upside: n/a
Jun 12, 2023
Reiterated: Sell
Price Target: $7
Current: $2.67
Upside: n/a
Mar 1, 2023
Reiterated: Buy
Price Target: $32 → $31
Current: $1.18
Upside: n/a
Feb 24, 2023
Reiterated: Buy
Price Target: $225
Current: $249.61
Upside: n/a
Nov 14, 2022
Initiated Coverage: Hold
Price Target: $22
Current: $4.72
Upside: n/a
Nov 11, 2022
Downgraded: Hold
Price Target: $30 → $7
Current: $11.04
Upside: n/a
Nov 10, 2022
Reiterated: Hold
Price Target: $2 → $1
Current: $7.06
Upside: n/a
Nov 9, 2022
Reiterated: Hold
Price Target: $8 → $9
Current: $4.03
Upside: n/a
Nov 3, 2022
Reiterated: Hold
Price Target: $34 → $6
Current: $2.57
Upside: n/a
Mar 4, 2021
Upgraded: Buy
Price Target: $28 → $30
Current: $3.45
Upside: n/a
Mar 1, 2021
Reiterated: Hold
Price Target: $126 → $131
Current: $430.36
Upside: n/a
Nov 9, 2020
Reiterated: Sell
Price Target: $11
Current: $1.08
Upside: n/a
Oct 28, 2020
Downgraded: Hold
Price Target: $40
Current: $3.58
Upside: n/a
May 8, 2020
Reiterated: Hold
Price Target: $45 → $47
Current: $59.90
Upside: n/a
Nov 13, 2019
Reiterated: Sell
Price Target: $4 → $2
Current: $6.20
Upside: n/a
Oct 29, 2013
Rated: Hold
Price Target: $44 → $76
Current: $598.72
Upside: n/a
Oct 15, 2013
Downgraded: Hold
Price Target: $18 → $2
Current: $1.92
Upside: n/a
Dec 2, 2011
Initiated Coverage: Buy
Price Target: $13
Current: $0.0001
Upside: n/a